Hims & Hers (HIMS) Taps Into $200-Billion Weight Loss Market, Soars 6%

Hims & Hers Health Inc. (NYSE:HIMS) is 1 of the 10 Stocks With Unexpected Gains.

Hims & Hers bounced backmost by 6.22 percent connected Monday to adjacent astatine $20.33 apiece, arsenic investors positioned their second-quarter portfolios backed by optimism implicit its rekindled concern with Novo Nordisk to jointly capitalize connected the $200 cardinal obesity attraction market.

Late past month, Hims & Hers Health Inc. (NYSE:HIMS) announced that Novo Nordisk’s blockbuster drugs, Wegovy and Ozempic, are present backmost connected its platform.

Eligible customers seeking to acquisition the said treatments tin avail some pill and injectable versions of Wegovy, but for the 7.2 mg injection, which has yet to beryllium launched. Ozempic injectable pens are besides disposable crossed each dosages.

Nestor Rizhniak/Shutterstock.com

“As the largest planetary user wellness platform, we’re thrilled to beryllium moving alongside Novo Nordisk to assistance much radical consciousness their champion and we’re excited to find much ways to collaborate crossed the industry,” said Hims & Hers Health Inc. (NYSE:HIMS) CEO Andrew Dudum.

For his part, Hims & Hers Health Inc. (NYSE:HIMS) SVP for Weight Management Craig Primack noted that obesity medications person evolved implicit the past respective years to go much affordable, much flexible, and much approachable for each benignant of patient.

“As a portion of our broad attraction program, these FDA-approved medications volition assistance much radical get and enactment healthy. We’re excited to spot however our customers win arsenic much innovative treatments go available,” helium noted.

In a survey published successful February this year, JPMorgan said that it expects the planetary incretin marketplace to soar to arsenic overmuch arsenic $200 cardinal implicit the adjacent 4 years, acknowledgment to reduced prices and continued beardown request for value nonaccomplishment treatments.

It noted that the fig of Americans unsocial adopting the attraction is projected to soar by 150 percent by 2030 to 25 cardinal from 10 cardinal previously.

While we admit the imaginable of HIMS arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey connected Google News.